22 August 2024 in 3D Printing and Additive Manufacturing
Materials based on the hydroxypropyl methylcellulose mixed with different biopolymers (BioP; 5 w% of chitosan, sodium alginate, apple pectin, or citrus pectin) were processed by hot-melt extrusion and 3D printing to produce capsules intended for controlled drug release. Microscopic analyses confirmed significant impact of BioP on the processing temperatures and quality of the 3D printing. The capsules’ chemical composition had a more significant impact on the dissolution profiles in acidic and neutral media, which are a robust function of the intermolecular bonds and swelling characteristics of the particular BioP (as indicated by the combined results of Raman spectroscopy, differential scanning calorimetry [DSC], and thermogravimetry). The capsules of all tested compositions retained the model drug for 120 min in pH 1.2, i.e., fulfilled the condition of targeting the small intestine. The presence of the particular BioP was found to be particularly beneficial in the development of personalized capsules for oral administration. The addition of both pectins led to a relatively fast pH-independent release of the model drug and has the potential applications in the targeting of the duodenum or jejunum. The capsules containing alginate and chitosan exhibited later initial release in pH 1.2, guaranteeing an unaltered passage through the stomach environment.
20 February 2025 in Macromolecular Materials and Engineering
This study introduces a novel approach to prepare an intestine‐targeting transport system with a controlled drug release profile, combining two 3D printing techniques: selective laser sintering (SLS) and fused deposition modeling (FDM). Material evaluations indicate that a mixture of Kollidon® VA64 with 20% of Kollicoat® IR and 0.2% of Aeroperl® has the best flow behavior and exhibits optimal printability at a laser speed of 90 mm s−1. The formulation is subsequently drug‐loaded and the printed cores are coated using the FDM technique. The core serves as a drug carrier and the FDM coating shell, consisting of 95% HPMC and 5% pectin, provides modified drug release and enhanced mechanical resistance of the tablet. The coating exhibits acid‐resistant properties, with no drug release in the pH of 1.2 during the first 120 min of dissolution testing. In the pH of 6.8, the release profile shows zero‐order kinetics with a constant release rate of 0.249% min−1 (in the time interval from 255 to 480 min). At the time point of 720 min, 92% of the drug is released. Dissolution testing thus demonstrates delayed and prolonged drug release. Combining both 3D printing methods shows great potential for personalized treatment of intestinal inflammatory diseases.
28 November 2024 in 3D Printing and Additive Manufacturing
This study shows the possibility of processing carbohydrate-based composite material (hypromellose and pectin from citrus peel) by a hot-melt extrusion (HME) process for bio-based filament preparation. Filaments with suitable mechanical and physicochemical properties were applied for fused deposition modeling (FDM) of peroral drug forms. The emphasis is placed on two 3D-printed forms applicable in pharmacy: FDM-printed coatings for matrix tablets (prepared by direct compression method) and capsules, both designed in appropriate software (Fusion®360). Each studied form was subjected to dimensional analysis to verify the reproducibility and stability of the 3D printing (3DP) process. Poly(vinylalcohol) (PVA) filament (the only commercial filament suitable in the pharmacy field) was used as a reference for the eligibility assessment of the designed 3D models. Two groups of the prepared dosage forms (coated matrix tablets, capsules) were tested by in vitro dissolution studies following European Pharmacopoeia. Detailed results of the dissolution study are summarized in this article. 3D printed coatings and capsules from bio based filament enable delayed drug release, which is in high demand for colon-targeted drug delivery. Next, the dosage forms made of PVA show lower lag times, whereas PVA capsules show potential in stomach-targeted drug delivery. Moreover, scanning electron microscopy analysis of the drug forms revealed the influence of the pectin particles on the consistency of the 3D-printed layers. Thermal stability of the processing materials was also studied by differential scanning calorimetry. No less important part is the practical application of a one-screw manual extruder for the preparation of biocomposite-based filaments. Obtained practical knowledge of HME and FDM 3DP processes are discussed and compared with the available machine learning prediction model M3DISEEN.
9 May 2025 in Journal of Pharmaceutical Sciences